The European Platform for Neurodegenerative Diseases (EPND) is proud to announce the release of the ATN dataset from its first biomarker case study, now accessible via the EPND Hub. This marks a major ...
The development of blood-based biomarkers for Alzheimer’s disease has fueled progress for both research and clinical translation. Now scientists want to do the same for other neurodegenerative ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results